1- (biphenyl-4-ylmethyl) imidazolidine-2, 4-dione derivatives and their use as CB2 receptor agonists

Details for Australian Patent Application No. 2009324120 (hide)

Owner N.V. Organon

Inventors Van Der Stelt, Marcelis; Cals, Joseph Maria Gerardus Barbara

Agent Spruson & Ferguson

Pub. Number AU-A-2009324120

PCT Pub. Number WO2010/063721

Priority 08170483.5 02.12.08 EP

Filing date 1 December 2009

Wipo publication date 10 June 2010

International Classifications

C07D 233/74 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/454 (2006.01)

A61K 31/5375 (2006.01) - 1,4-Oxazines, e.g. morpholine

A61K 31/54 (2006.01) - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

C07D 401/10 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

26 May 2011 PCT application entered the National Phase

  PCT publication WO2010/063721 Priority application(s): WO2010/063721

22 December 2011 Alteration of Name

  The name of the applicant has been altered to MSD Oss B.V.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009324121-Method for sterilizing liquid and liquid sterilization device

2009324116-Vessel for cooling syngas